InsidersTradesSigma
药易购 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Track the 药易购 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 药易购 has recorded 9 insider filings. Market capitalisation: €3.3bn. The latest transaction was reported on 3 July 2025 (Sale). Among the most active insiders: 田文书. Every trade is accessible without an account.
9
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
8 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,859 of 25,829 companies
19.4
score / 100
Value21
Quality17
FCF yld-1.1%
Earn yld-0.7%
EV/EBITDA48.8x
ROE-2.4%
Gross mgn10%
Net mgn-0.3%
Debt/EBITDA7.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2025
Declarations9 total
9 of 9 declarations